In our experiments, the anti-breast cancer drug Chidamide acts on breast cancer cells to activate Nestin expression through LncRNA ENST869, and this “inappropriate expression” is just the result of self-protection of cancer cells against drugs, suggesting that Nestin may participate in the pharmacological action against Chidamide, which may be the key in breast cancer cell drug resistance. This evidence concerns the gene NES and breast cancer.